VEGFA Mouse Monoclonal Antibody [Clone ID: OTI4G3]
CAT#: TA500042S
VEGFA (VEGF) mouse monoclonal antibody, clone OTI4G3 (formerly 4G3)
Size: 100 ul
View other "OTI4G3" antibodies (4)
Need it in bulk or conjugated?
Get a free quote
CNY 800.00
Cited in 2 publications. |
CNY 300.00
CNY 1,430.00
CNY 3,080.00
Specifications
Product Data | |
Clone Name | OTI4G3 |
Applications | WB |
Recommend Dilution | WB 1:2500~5000 |
Reactivity | Human, Dog |
Host | Mouse |
Clonality | Monoclonal |
Immunogen | Human recombinant protein fragment corresponding to amino acids 27-233 of human VEGFA (NP_003367) produced in E.coli. |
Formulation | PBS (pH 7.3) containing 1% BSA, 50% glycerol and 0.02% sodium azide. |
Concentration | 0.46 mg/ml |
Purification | Purified from mouse ascites fluids or tissue culture supernatant by affinity chromatography (protein A/G) |
Conjugation | Unconjugated |
Storage Condition | Store at -20°C as received. |
Predicted Protein Size | 23.8 kDa |
Gene Name | vascular endothelial growth factor A |
Database Link | |
Background | VEGF is a member of the PDGF/VEGF growth factor family that is often found as a disulfide linked homodimer. It is a glycosylated mitogen that specifically acts on endothelial cells and has various effects, including mediating increased vascular permeability, inducing angiogenesis, vasculogenesis and endothelial cell growth, promoting cell migration, and inhibiting apoptosis. Elevated levels of this protein is linked to POEMS syndrome, also known as Crow-Fukase syndrome. Mutations in VEGF gene have been associated with proliferative and nonproliferative diabetic retinopathy. |
Synonyms | MVCD1; VEGF; VPF |
Reference Data | |
Protein Families | Druggable Genome, Secreted Protein |
Protein Pathways | Bladder cancer, Cytokine-cytokine receptor interaction, Focal adhesion, mTOR signaling pathway, Pancreatic cancer, Pathways in cancer, Renal cell carcinoma, VEGF signaling pathway |
Citations (2)
The use of this Antibodies has been cited in the following citations: |
---|
ADAMTS9 is Silenced by Epigenetic Disruption in Colorectal Cancer and Inhibits Cell Growth and Metastasis by Regulating Akt/p53 Signaling
,Chen, L;Tang, J;Feng, Y;Li, S;Xiang, Q;He, X;Ren, G;Peng, W;Xiang, T;,
Cell. Physiol. Biochem.
,PubMed ID 29186710
[VEGFA]
|
The 3p14.2 tumour suppressor ADAMTS9 is inactivated by promoter CpG methylation and inhibits tumour cell growth in breast cancer
,Shao, B;Feng, Y;Zhang, H;Yu, F;Li, Q;Tan, C;Xu, H;Ying, J;Li, L;Yang, D;Peng, W;Tang, J;Li, S;Ren, G;Tao, Q;Xiang, T;,
J. Cell. Mol. Med.
,PubMed ID 29193730
[VEGFA]
|
Documents
Product Manuals |
FAQs |
SDS |
Resources
抗体相关资料 |
Other Versions
SKU | Description | Size | Price |
---|---|---|---|
CF500042 | Carrier-free (BSA/glycerol-free) VEGF mouse monoclonal antibody, clone OTI4G3 (formerly 4G3) |
CNY 3,999.00 |
|
TA500042 | VEGFA (VEGF) mouse monoclonal antibody, clone OTI4G3 (formerly 4G3) |
CNY 1,999.00 |
|
TA500042AM | VEGF mouse monoclonal antibody, clone 4G3, Biotinylated |
CNY 3,990.00 |
|
TA500042BM | VEGF mouse monoclonal antibody, clone 4G3, HRP conjugated |
CNY 3,990.00 |